Beta Bionics BBNX Ratios (2023-2026)

NASDAQ BBNX
$19.47 -0.54 (-2.71%)
At close: Aug 20, 2026 · 12:08 PM UTC
Ratios Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin (Quarter) 55.68%53.73%53.36%57.19%50.86%53.80%55.48%58.98%59.50%59.04%
EBT Margin (Quarter) -68.15%-75.04%-64.36%-62.06%-353.87%-261.24%-303.68%-44.41%-157.96%-201.05%
EBIT Margin (Quarter) -73.09%-78.32%-65.71%-63.78%-105.69%-85.52%-62.54%-50.20%-87.86%-79.90%
EBITDA Margin (Quarter) -73.09%-78.32%-65.71%-63.78%-105.69%-85.52%-62.54%-50.20%-87.86%-79.90%
Operating Margin (Quarter) -73.09%-78.32%-65.71%-63.78%-105.69%-85.52%-62.54%-50.20%-87.86%-79.90%
Net Margin (Quarter) -68.15%-75.04%-64.36%-62.06%-353.87%-261.24%-303.68%-44.41%-157.96%-201.05%
FCF Margin (Quarter) -97.04%-84.99%-68.79%-72.60%-115.13%-66.15%-36.73%-32.78%-91.25%-48.92%
Efficiency
Inventory Average (Quarter) 14.53M16.53M18.85M21.05M22.72M23.82M
Assets Average (Quarter) 243.83M334.00M330.01M329.39M316.58M298.40M
Asset Utilization Ratio (Quarter) 0.290.230.270.300.350.40
Leverage & Solvency
Interest Coverage Ratio (Quarter) -18.91-23.57-18.30-21.73-0.40-0.45-0.25-20.16-1.12-0.62
Times Interest Earned (Quarter) -18.91-23.57-18.30-21.73-0.40-0.45-0.25-20.16-1.12-0.62
Valuation
Enterprise Value (Quarter) -96.75M-22.07M-13.03M-17.48M-103.58M-231.47M-249.72M-228.69M-219.12M-199.52M-180.49M
Return Ratios
Return on Sales (Quarter) -0.01%-0.01%-0.01%-0.01%-0.04%-0.03%-0.03%0.00%-0.02%-0.02%
Return on Capital Employed (Quarter) -23.95%-19.88%-22.52%-24.02%-26.35%-30.48%
Return on Assets (Quarter) 0.00%0.00%-0.01%-0.01%-0.01%-0.01%